Exagen Inc.
USD4.86
+0.18 (+3.85%)
CEO
John Aballi
IPO Date
2019-09-19
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Country
US
Open
$4.84
Prev. Close
$4.68
Day Low
$4.63
Day High
$4.95
52W Low
$2.59
52W High
$12.23
Market Cap
$0.12B
Volume
0.23M
| 37,500 |
| $4.31 |
| 22 Jun 2026 | Stokes Frank | director | A-Award | Acquired | 37,500 | $4.31 |
| 21 Apr 2026 | McKhann Chas | director | Disposed | 0 | $0.00 |
| 16 Mar 2026 | McKhann Chas | director | Disposed | 0 | $0.00 |
| 16 Mar 2026 | Black Jeffrey G. | Chief Financial Officer | A-Award | Acquired | 75,000 | $3.16 |
| 16 Mar 2026 | Black Jeffrey G. | Chief Financial Officer | A-Award | Acquired | 1,511 | $3.08 |
| 16 Mar 2026 | Black Jeffrey G. | Chief Financial Officer | A-Award | Acquired | 50,000 | $3.16 |
| 16 Mar 2026 | ABALLI JOHN | director, officer: President and CEO | A-Award | Acquired | 150,000 | $0.00 |
| 16 Mar 2026 | ABALLI JOHN | director, officer: President and CEO | A-Award | Acquired | 100,000 | $3.16 |